National Asset Management, Inc. Takeda Pharmaceutical CO LTD Transaction History

National Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$13.17 - $16.4 $1.45 Million - $1.8 Million	-109,995 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$16.3 - $17.26 $159,251 - $168,630	-9,770 Reduced 8.16%	109,995 $1.8 Million
Q2 2021 Aug 10, 2021	BUY	$16.55 - $18.64 $691,938 - $779,319	41,809 Added 53.63%	119,765 $2.02 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $1.3 Million - $1.55 Million	77,956 New	77,956 $1.43 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.